Milestone Scientific Welcomes Dr. Sayed to Board for Progress
Milestone Scientific's Strategic Addition of Dr. Dawood Sayed
Milestone Scientific Inc. (MLSS), a pioneer in the development of advanced drug delivery systems, has announced the appointment of Dr. Dawood Sayed to its Board of Directors. Dr. Sayed, a recognized authority in interventional pain medicine, will provide invaluable insights as the company pursues its goals in innovative pain management.
About Dr. Dawood Sayed's Expertise
Dr. Sayed is currently a Professor of Anesthesiology and Pain Medicine at the University of Kansas Medical Center. His roles include Division Chief of Pain Medicine and Director of Interventional Spine Services. His extensive experience and deep understanding of minimally invasive procedures equip him to enhance Milestone Scientific's mission.
Contributions to Pain Management
In addition to his academic roles, Dr. Sayed is the Vice Chairman and Co-Founder of the American Society of Pain and Neuroscience (ASPN). His influence extends through collaborations with commercial payers and regulators to ensure access to advanced pain relief technologies. His leadership has been recognized with various awards, including the prestigious Presidential Award from the North American Neuromodulation Society.
Company Insights on Strategic Growth
Neal Goldman, Chairman of Milestone Scientific, expressed enthusiasm about Dr. Sayed’s appointment. He believes that Dr. Sayed’s profound expertise will be crucial for the company's expansion in the pain management sector. This strategic decision fills a vital role in ensuring that Milestone Scientific adapts to both patient and physician needs in a dynamic healthcare environment.
The Impact of CompuFlo® Technology
Milestone Scientific’s CompuFlo® Epidural System represents a transformative technology that enhances safety and precision during injections. This real-time feedback mechanism allows practitioners to accurately identify the epidural space, improving overall procedural outcomes and reducing the risks often associated with traditional methods.
A Future Driven by Innovation
Looking toward growth, Eric Hines, CEO of Milestone Scientific, emphasized that Dr. Sayed’s background will aid in developing strategies for clinical adoption and reimbursement. As the company embraces this next stage, it aims to solidify its presence in the interventional pain management field. Dr. Sayed is eager to play a part in this journey, advocating for innovative solutions that improve patient safety and reduce reliance on opioids.
Advancements in Clinical Research
With over 100 peer-reviewed publications and contributions to national pain management guidelines, Dr. Sayed is actively involved in multiple clinical trials dedicated to neuromodulation and spinal therapies. His role as a medical advisor to leading technology innovators enhances his ability to guide Milestone Scientific in navigating the evolving landscape of medical technology.
About Milestone Scientific Inc.
Milestone Scientific Inc. is committed to revolutionizing the medical and dental fields with its patented technologies designed for improved injection techniques. Utilizing its unique Dynamic Pressure Sensing Technology (DPS®), Milestone’s systems aim to increase efficiency and comfort, while also ensuring patient safety.
Frequently Asked Questions
What is Milestone Scientific Inc. known for?
Milestone Scientific is known for developing innovative drug delivery technologies, particularly aimed at improving pain management outcomes.
Who is Dr. Dawood Sayed?
Dr. Dawood Sayed is a leading expert in interventional pain medicine, appointed to Milestone Scientific’s Board of Directors to enhance its strategic capabilities.
What technology does Milestone Scientific offer?
The company offers the CompuFlo® Epidural System, a technology that uses real-time pressure feedback to improve the accuracy and safety of epidural injections.
What are the goals of Milestone Scientific's recent appointment?
The appointment of Dr. Sayed is aimed at advancing clinical adoption of innovative technologies that improve patient outcomes in pain management.
How does Milestone Scientific approach innovation?
Milestone Scientific invests in research and development to create cutting-edge injection technologies that prioritize patient safety and comfort.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.